Floatz logo

Anti-Kirsten Rat Sarcoma Virus Glycine To Aspartic Acid Substitution At Codon 12 Peripheral Blood Lymphocytes

Rectal Cancer

National Cancer Institute (NCI)Cell therapyPhase 1/2Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
73/ 100

Competitive context

114 Active assets in the Rectal Cancer cohort.

Asset / SponsorPhaseRating
Irinotecan
Fudan University
Phase 2BBB
Capecitabine
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4BBB
Eloxatin
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3BBB
Floxuridine
City of Hope Medical Center
Phase 2BBB
FLUOROURACILUM
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3BBB

View all 50 →

Same molecule, other indications

Anti-Kirsten Rat Sarcoma Virus Glycine To Aspartic Acid Substitution At Codon 12 Peripheral Blood Lymphocytes is also rated in:

digestive system cancerDormant
CC
Indicative ·
45 / 100
View asset →
gastric cancerDormant
CC
Indicative ·
41 / 100
View asset →
colon carcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →